Top compounds associated with response to LILRA2


Feature Type Standardized
Nominal ANOVA
mRNA pac-1 CTRPv2 pan-cancer AAC 0.018 0.6
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC -0.018 0.6
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.017 0.6
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.016 0.6
mRNA BRD-K41334119 CTRPv2 pan-cancer AAC 0.033 0.6
mRNA 968 CTRPv2 pan-cancer AAC -0.031 0.6
mRNA SR1001 CTRPv2 pan-cancer AAC -0.018 0.6
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.018 0.7
mRNA GSK1059615 CTRPv2 pan-cancer AAC -0.022 0.7
mRNA Bosutinib CTRPv2 pan-cancer AAC 0.016 0.7
Download CSV